Related Experiment Video
Updated: May 11, 2026

Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics
Published on: January 11, 2019
Splice variants DNMT3B4 and DNMT3B7 overexpression inhibit cell proliferation in 293A cell line
Abstract:
DNA methyltransferase 3B (DNMT3B) is critical in abnormal DNA methylation patterns in cancer cells. Nearly 40 alternatively spliced variants of DNMT3B have been reported. DNMT3B4 and DNMT3B7 are two kinds of splice variants of DNMT3B lacking the conserved methyltransferase motif. In this study, the effect of inactivation of DNMT3B variants, DNMT3B4 and DNMT3B7, on cell proliferation was assessed. pCMV-DNMT3B4 and pCMV-DNMT3B7 recombinant plasmids were developed and stably transfected into 293A cells. 293A cells transfected with plasmid pCMV-DNMT3B4 or pCMV-2B were then treated with G418 to the stable cell lines. After that, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide method was used for testing the proliferation level, and flow cytometry was used to test cell cycle distribution of the cell line. The expression of p21 was detected by real-time PCR and Western blot. The methylation status of p21 promoter was detected by methylation-specific PCR (MS-PCR). It was found that DNMT3B4 and DNMT3B7 overexpression could inhibit cell proliferation and increase the expression of p21. Cell cycle analysis demonstrated that inactivation of DNMT3B variants overexpression inhibited cell cycle progression. Inactivation of DNMT3B variants overexpression facilitated p21 expression to delay 293A cell proliferation. These findings indicate that inactivation of DNMT3B variants might play an important role in cell proliferation correlating with the change of p21.
Insights
Inactivating DNA methyltransferase 3B (DNMT3B) variants, specifically DNMT3B4 and DNMT3B7, inhibits cancer cell proliferation by increasing p21 expression and delaying cell cycle progression.
Area of Science:
- Molecular Biology
- Cancer Research
- Epigenetics
Background:
- DNA methyltransferase 3B (DNMT3B) plays a key role in aberrant DNA methylation in cancer.
- Numerous alternatively spliced variants of DNMT3B exist, including DNMT3B4 and DNMT3B7, which lack the methyltransferase motif.
Purpose of the Study:
- To investigate the impact of inactivating DNMT3B variants (DNMT3B4 and DNMT3B7) on cancer cell proliferation.
- To explore the underlying molecular mechanisms involving p21 expression and cell cycle regulation.
Main Methods:
- Stable transfection of 293A cells with pCMV-DNMT3B4 and pCMV-DNMT3B7 recombinant plasmids.
- Assessment of cell proliferation using the MTT assay.
- Analysis of cell cycle distribution via flow cytometry.
- Detection of p21 expression (mRNA and protein) using real-time PCR and Western blot.
- Evaluation of p21 promoter methylation using methylation-specific PCR (MS-PCR).
Main Results:
- Overexpression of DNMT3B4 and DNMT3B7 inhibited cell proliferation.
- DNMT3B variant inactivation led to increased p21 expression.
- Cell cycle analysis revealed inhibited progression in cells overexpressing DNMT3B variants.
- Inactivation of DNMT3B variants promoted p21 expression, delaying cell proliferation.
Conclusions:
- Inactivation of DNMT3B variants (DNMT3B4 and DNMT3B7) can suppress cancer cell proliferation.
- The observed anti-proliferative effect is associated with enhanced p21 expression and cell cycle delay.
- These findings highlight a potential role for DNMT3B variants in cancer cell proliferation control.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
Inhibition of Cdk Activity

